Reveal LINQ vs Affiniti Series Diagnostic Ultrasound Systems
AI Verdict
Choose Reveal LINQ if…
Choose Reveal LINQ if you require long-term, continuous cardiac monitoring for up to three years to diagnose infrequent or elusive arrhythmias, such as those associated with cryptogenic stroke, unexplained syncope, or suspected atrial fibrillation. Its implantable nature and AI-powered algorithms are ideal for capturing events that might be missed by shorter-term monitoring methods, providing a comprehensive diagnostic picture.
View Reveal LINQ →Choose Affiniti Series Diagnostic Ultrasound Systems if…
Choose Philips Affiniti Series Diagnostic Ultrasound Systems if your facility needs a versatile, high-quality ultrasound solution for real-time diagnostic imaging across multiple specialties like cardiology, obstetrics/gynecology, and radiology. Its advanced imaging technologies and efficient workflows are designed to deliver diagnostic confidence and reproducibility for a broad range of patient examinations.
View Affiniti Series Diagnostic Ultrasound Systems →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ | Affiniti Series Diagnostic Ultrasound Systems |
|---|---|---|
| Pricing | Unknown | Varies by model and condition (new/refurbished). generally considered a 'mid tier' or 'budget' shared service ultrasound with rich image quality at an affordable price point compared to premium models. |
| Deployment | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. | On-premise (console hardware system) |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Reveal LINQTool A (Reveal LINQ) offers a minimally invasive, implantable solution for patients and a mobile app for clinicians, streamlining long-term monitoring with wireless data transmission. While Tool B (Affiniti Series) emphasizes efficient workflows for sonographers, Tool A's approach provides a less intrusive patient experience and remote management for clinicians, making it more 'usable' in terms of patient comfort and continuous, passive data collection.
Clinical Value
Reveal LINQTool A (Reveal LINQ) provides continuous, long-term ECG monitoring with AI algorithms specifically designed to accurately detect and diagnose intermittent cardiac arrhythmias, including AF and cryptogenic stroke, and to reduce false alerts. This addresses a critical and often challenging diagnostic gap. While Tool B (Affiniti Series) offers advanced diagnostic imaging across multiple specialties, Tool A's targeted AI for hard-to-catch conditions offers a more distinct and impactful clinical advantage in its specific domain.
Pricing & Value
Affiniti Series Diagnostic Ultrasound SystemsTool B (Affiniti Series) provides transparent pricing details, positioning itself as a 'mid-tier' or 'budget' option with specific refurbished price ranges, allowing buyers to clearly assess its value proposition. In contrast, Tool A (Reveal LINQ) requires direct vendor contact for pricing, which is common for implantable devices but makes it difficult to compare and evaluate its cost-effectiveness without further inquiry.
Enterprise Readiness
Affiniti Series Diagnostic Ultrasound SystemsBoth tools are FDA cleared and HIPAA compliant, essential for enterprise use. However, Tool B (Affiniti Series) explicitly states it 'has BAA: 1' (yes), whereas Tool A's BAA is 'implied by HIPAA compliance.' Additionally, Tool B represents a standard on-premise console system, which aligns with traditional enterprise deployment models for imaging departments, giving it a slight edge in explicit compliance and conventional integration.
Innovation
Reveal LINQTool A (Reveal LINQ) demonstrates significant innovation through its 'world's smallest' insertable cardiac monitor and the use of AccuRhythmu2122 AI algorithms for reduced false alerts in continuous, long-term ECG monitoring. This combination of miniaturization and targeted AI for a chronic diagnostic challenge represents a more disruptive advancement in cardiac monitoring. While Tool B (Affiniti Series) features numerous advanced imaging technologies, they are primarily enhancements within an established diagnostic modality.
Support & Docs
TieNeither the provided structured facts nor general web searches revealed a clear differentiator in the quality or availability of support and documentation between Medtronic (Tool A) and Philips (Tool B). Both are major medical device manufacturers with extensive resources, implying comprehensive support and documentation for their respective products.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ | Affiniti Series Diagnostic Ultrasound Systems |
|---|---|---|
| Name | Reveal LINQ | Affiniti Series Diagnostic Ultrasound Systems |
| Company | Medtronic | Philips Ultrasound |
| Description | Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. | The Philips Affiniti Series Diagnostic Ultrasound Systems offer advanced imaging for diverse clinical needs, featuring PureWave technology, Anatomical Intelligence, and efficient workflows for confident diagnosis. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, OB/GYN AI, Radiology & Imaging AI |
| Specialties | Cardiology, Neurology | Cardiology, Obstetrics & Gynecology, Radiology |
| Key Features | World's smallest insertable cardiac monitor (1.2 mL), Continuous ECG monitoring for up to three years, AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause), Automatic and patient-activated event recording, MRI Conditional (1.5T and 3T) with no post-insertion waiting, Minimally invasive, simplified insertion procedure, Wireless data transmission to CareLinku2122 network via MyCareLinku2122 Patient Monitor, Reveal LINQu2122 Mobile Manager app for clinician device management | PureWave crystal technology, Tissue Specific Presets (TSPs), Anatomical Intelligence Ultrasound (AIUS), xMatrix transducer technology (for versatile data acquisition), NextGen Auto Scan (adaptive image optimization), TrueVue and FlexVue (photorealistic OB/GYN imaging), Flow Viewer and MicroFlow Imaging (MFI), ShearWave and Strain elastography |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ and Affiniti Series Diagnostic Ultrasound Systems.